Enzo Biochem, Inc.

NYSE:ENZ  
2.29
0.00 (0.00%)
7:13:57 PM EDT: $2.42 +0.13 (+5.68%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Enzo Biochem, Inc. Stock, NYSE:ENZ

81 Executive Boulevard, Suite 3, New York, New York 10022
United States of America
Phone: +1.212.583.0100
Number of Employees: 520

Description

Enzo Biochem, Inc. is an integrated diagnostics, clinical lab, and life sciences company, which focuses on delivering and applying advanced technology capabilities to produce affordable reliable products and services that enable customers to meet their clinical needs. It operates through the following segments: Products, Clinical Services, and Therapeutics. The Products segment develops, manufactures, and markets products to research and pharmaceutical customers. The Clinical Services segment provides diagnostic services to the health care community. The Therapeutics segment conducts research and development activities for therapeutic drug candidates. The company was founded by Elazar Rabbani, Barry W. Weiner and Shahram K. Rabbani in 1976 and is headquartered in New York, NY.